Skip to content

lifestyle.ideawins.com

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment

    Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment

    Aclarion, Inc.
    October 8, 2026
  • Gain Therapeutics to Attend the 2026 Maxim Growth Summit

    Gain Therapeutics to Attend the 2026 Maxim Growth Summit

    Gain Therapeutics, Inc.
    October 8, 2026
  • Global M&A Completion Rates Rise Despite Softer Pipeline in 3Q26, Datasite Data Shows

    Global M&A Completion Rates Rise Despite Softer Pipeline in 3Q26, Datasite Data Shows

    Datasite
    October 8, 2026
  • Josie Sutcliffe Joins ChartHop to Lead Marketing

    Josie Sutcliffe Joins ChartHop to Lead Marketing

    ChartHop
    October 8, 2026
  • Aspire To Unveil Command Center at Ignite 2026, Bringing AI-Powered Insights and Action Together for Landscape Contractors

    Aspire To Unveil Command Center at Ignite 2026, Bringing AI-Powered Insights and Action Together for Landscape Contractors

    ServiceTitan
    October 8, 2026
  • FieldRoutes To Unveil Next Phase of Product Innovation at Ignite 2026

    FieldRoutes To Unveil Next Phase of Product Innovation at Ignite 2026

    ServiceTitan
    October 8, 2026
  • A Partnership for Pets: Simon Cowell and Trupanion Team Up

    A Partnership for Pets: Simon Cowell and Trupanion Team Up

    Trupanion, Inc.
    October 8, 2026
  • Muon Space Expands Leadership Team as Company Scales Constellation Programs

    Muon Space Expands Leadership Team as Company Scales Constellation Programs

    Muon Space Inc
    October 8, 2026
  • Lexeo Therapeutics to Participate in the Chardan Healthcare Conference

    Lexeo Therapeutics to Participate in the Chardan Healthcare Conference

    Lexeo Therapeutics
    October 8, 2026
  • Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia

    Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia

    Cullinan Therapeutics, Inc.
    October 8, 2026
1 2 3 … 33,319
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.